Overview

The Effect of Prophylactic Anticoagulation on Major Bleeding Events in Hospitalized Chronic Kidney Disease and Lower Limb Fracture Patients.

Status:
COMPLETED

Trial end date:
2024-12-01

Target enrollment:

Participant gender:

Summary

the risk of bleeding may be greater than the benefit of antithrombotic protection when prophylactically anticoagulating a patient with a lower limb fracture and advanced CKD. The primary objective was to evaluate the risk major bleeding in patients with lower limb fractures and advance CKD. The secondary objectives were to assess major bleeding in patients with lower limb fractures in CKD stage 4 and 5, thrombosis, death.

Phase:

PHASE2

Details

Lead Sponsor:

Hospital Civil de Guadalajara

Treatments:

Enoxaparin